Jupiter Life Line Hospitals Ltd

Stage 4 · Declining · week 3

As of 20 Nov 2026, Jupiter Life Line Hospitals is in Stage 4, the downtrend phase, now in week 3 (since 3 Nov 2026). It closed at ₹317, 4.5% below its 52-week high and above its 200-day average, which is rising. In Health Care, 34.7% of stocks are in Stage 2.

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. More about the company

₹317.4
Close, 20 Nov 2026
+12.87% on the day
₹10,405 Cr · Mid cap
Market DowntrendHealth Care 34.7% in Stage 2-11.4 pts / 20dHospitals & Diagnostic Centres 18.8%-3.1 pts

Pro read

Pro

Our read

Declining, below its long-term trend

Setup score

—

RS rank

Edge

—

JLHL is in a decline, 17% above its 200-day average. Declining stocks have lagged the market more than any other group; we wait for a base before looking again.

Its relative strength is 71 of 99, above the middle among NSE stocks over the past year. Hospitals & Diagnostic Centres ranks 15 of 106 industries by the strength of its stocks, among the leaders.

Is JLHL early, or has it already run? Pro answers that for every NSE stock, after every close.

Loading price chart…
Stage Cycle Timeline2023-09-18 → 2026-11-20
S? 43w
S2 33w
S4 20w
2023-09-182026-11-20
S1S2S3S4Setup score (0–10, dashed line at 5)
S? 43w → S2 33w → S3 5w → S2 3w → S3 7w → S4 5w → S1 5w → S4 8w → S1 3w → S2 5w → S3 2w → S4 20w → S1 9w → S2 10w → S3 6w → S4 3w current
Total tracked: 165 weeks across 16 stage runs.

JLHL among Hospitals & Diagnostic Centres13th of 32 by relative strength

All 32 →
Stocks in Hospitals & Diagnostic Centres ranked by relative strength, with stage and one-month change
#StockStageRS1M
1KMCSHILStage 2 · wk 5498+35.8%
2VIJAYAStage 3 · wk 290+16.2%
3YATHARTHStage 2 · wk 2789+18.6%
4LALPATHLABStage 2 · wk 2383+9.3%
5APOLLOHOSPStage 3 · wk 782+21.1%
6MEDANTAStage 3 · wk 581+20.1%
7KIMSStage 4 · wk 178+18.0%
8METROPOLISStage 3 · wk 677+6.1%
…13JLHLStage 4 · wk 371+28.8%
vs 52W High
-4.5%
₹239.7 lo₹332.4 hi
4.5% below 52W high, failed near resistance
In Stage 4, distance from the 52-week high reflects an ongoing decline, not a discount.
Stage Maturity
Week 3
1w13w26w
Week 3, early Stage 4 decline
How long this stock has been in Stage 4 decline. The longer the downtrend, the more entrenched the selling pressure. No length of decline marks a bottom on its own.
vs 200 DMA
16.8%
200 DMA: ₹271.7 · rising
The stock is above its 200-day average while still in Stage 4. Stage analysis looks for it to hold there, and for the line to turn up, before reading a change of trend.
Rel Volume
120.93x
vs 50-day avg
Volume ran well above average on an up day. Bounces in a Stage 4 decline need follow-through over several sessions before they mean much.
Trend Health
↑ ⇈
Short-term trend rising strongly, and accelerating
Two reads of momentum. The arrow shows the direction of the short-term trend: rising (↑ or ↗), flat (→) or rolling over (↓). The ⇈ mark appears when our trend model reads the move as gaining speed on top of the longer trend. Strongest when both agree.
1M
+28.8%
3M
-1.0%
6M
+20.5%
YTD
+14.0%
1Y
+6.0%
Sector
Health Care
↓ Peaking
Stage 2%
34.7%
20d Δ
-11.4pp
1M return
+11.5%
3M return
+3.8%
Sector Stage-2 % · last 20 days
Sector has 58 Stage 2 leaders. See Health Care Stage 2 →
Industry
Hospitals & Diagnostic Centres
↓ Peaking
Stage 2%
18.8%
20d Δ
-3.1pp
1M return
+17.6%
3M return
+0.9%
Industry Stage-2 % · last 20 days
Industry has 5 Stage 2 leaders. See Hospitals & Diagnostic Centres Stage 2 →

Mutual fund holdings

Held by 18 mutual funds in portfolios to October 2026: 13 active funds and 5 index funds and ETFs.

In October, among active funds: 3 increased and 1 reduced.

3 increased or opened1 reduced or exited
All 18 funds and what each did in October

Mutual funds holding JLHL: the ten largest and the month’s moves →

Fund details on DiscoverMF

Scan Membership
Not in any scan now.
Last appeared 27 Aug 2026
Last appeared 27 Aug 2026
Last appeared 20 Jul 2026
Recent Stage Timeline
2026-11-20S4
Wk 3 · Vol 120.93x
2026-11-19S4
Wk 3 · Vol 0.65x
2026-11-18S4
Wk 3 · Vol 0.24x
2026-11-17S4
Wk 2 · Vol 0.63x
2026-11-16S4
Wk 2 · Vol 0.43x
2026-11-13S4
Wk 2 · Vol 0.31x
2026-11-12S4
Wk 2 · Vol 0.44x
2026-11-11S4
Wk 2 · Vol 0.46x
2026-11-09S4
Wk 1 · Vol 0.14x
2026-11-06S4
Wk 1 · Vol 0.18x
2026-11-05S4
Wk 1 · Vol 0.98x
2026-11-04S4
Wk 1 · Vol 0.80x
Moving averages & range
50 DMA
₹267.6
200 DMA
₹271.7
52W High
₹332.4
52W Low
₹239.7
5D Low
₹281.2
Resistance levels (recent highs)
20d High
₹317.4
60d High
₹317.4
120d High
₹332.4
250d High
₹332.4
Next resistance
+4.7%
to 120d High
P/E (TTM)
51.9
Forward 38.7
Earnings Growth (YoY)
-1.7%
Revenue +16.0%
ROE
+12.1%
Profit margin +11.5%
Dividend Yield
0.07%
P/B 5.7

Jupiter Life Line Hospitals: quick answers

What stage is Jupiter Life Line Hospitals in?

As of 20 Nov 2026, Jupiter Life Line Hospitals (JLHL) is in Stage 4, the downtrend phase. It entered Stage 4 on 3 Nov 2026 and is in week 3. What the four stages mean

Is Jupiter Life Line Hospitals in an uptrend?

No. Jupiter Life Line Hospitals is in a Stage 4 downtrend. It trades 16.8% above its 200-day average, which is rising.

How far is Jupiter Life Line Hospitals from its 52-week high?

Jupiter Life Line Hospitals closed at ₹317 on 20 Nov 2026, 4.5% below its 52-week high of ₹332. Its 52-week low is ₹240.

How has Jupiter Life Line Hospitals performed over the past year?

As of 20 Nov 2026, Jupiter Life Line Hospitals is up 6.0% over the past year and up 14.0% so far in 2026.

Which sector and industry is Jupiter Life Line Hospitals in?

Jupiter Life Line Hospitals is in the Hospitals & Diagnostic Centres industry, part of the Health Care sector. 61 stocks in Health Care are in Stage 2, 34.7% of the sector. See the Stage 2 stocks in Hospitals & Diagnostic Centres

About this companyHealth Care· Hospitals & Diagnostic Centres

Jupiter Life Line Hospitals Limited, a multi-specialty hospital, provides health care services under the Jupiter brand in India. The company offers treatments in the areas of bariatric surgery, breast care center, cardiac surgery, cardiology, chest medicine, dental care, dermatology, endocrinology and diabetes, ENT, gastroenterology, general surgery and minimal access surgery, hematology and BMT, HPB and surgical gastroenterology, infectious diseases, internal medicine, interventional radiology, mental health, nephrology, neurology, neurosurgery, nutrition and dietetics, Obs and gynecology, oncology, ophthalmology, organ transplant, orthopedics, pediatrics, pain clinic, plastic and cosmetic surgery, rehabilitation, rheumatology, robotic knee replacement, robotic surgery, TAVI/TAVR, and urology. It also operates hotel under the Fortune Park Lake City Hotel name in Thane. The company was incorporated in 2002 and is based in Mumbai, India.

Visit company website →

All analytics based on EOD data. Data as of 2026-11-20. Past data patterns are not indicative of future results. This page is a data analytics tool only.